News
Camargo Meets Growing Client Needs with Appointment of Industry Leader Steven Castillo as Vice President of Drug Development
(Cincinnati, Ohio; July 23, 2014) – Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, expands its leadership team and therapeutic expertise with the appointment of Steven A. Castillo as vice president of drug development.
With more than 25 years of research and global drug development experience, Castillo has the strategic skills needed to provide guidance through the complex drug development and approval pathway. His history of successful interactions with the Food and Drug Administration (FDA) is in high demand by clients.
“Steven is a tremendous asset to our team,” said Ken Phelps, president and CEO of Camargo. “His experience in each stage of drug development, combined with outstanding leadership qualities, strengthens our team and will better support the success of our clients.”
Before joining Camargo, Castillo was a biotechnology consultant. His comprehensive program management expertise includes clinical operations, clinical pharmacology, medical affairs, biostatistics, pharmacovigilance, legal, finance, business development and executive management.
Castillo also brings broad therapeutic expertise to Camargo. Over the course of his career, Castillo focused on a range of therapeutic development areas including infectious disease, oncology, ophthalmology, dermatology and biologics, and he also worked on combination products delivered through medical devices.
“Steven’s expansive therapeutic experience, specifically in immunology, will be valuable for our clients looking to move products through the 505(b)(2) approval pathway,” said Phelps.
Castillo is a member of the American Society for Cell Biology and his expertise has been showcased in numerous publications and presentations at conferences, including Clinical Infectious Diseases, the International AIDS Conference, Conference on Retroviruses and Opportunistic Infections and the Interscience Conference on Antimicrobial Agents and Chemotherapy.
About Camargo Pharmaceutical Services
Camargo Pharmaceutical Services is your full-service drug development partner specializing in the 505(b)(2) process. Before development even begins, we verify profit potential by working with your team to develop a comprehensive program and timeline complete with important milestones and cost objectives. We manage every facet of the plan throughout your development continuum, from feasibility assessments, formulation and testing the drug product, to conducting preclinical and clinical studies, to final submission. Connect with Camargo on LinkedIn, the President’s blog or visit www.camargopharma.com for more information.
###